1Suppliers
1Customers
1Debt Items
0Related Chains

NextCure, Inc. Suppliers

TickerNameConfidenceEvidence
LIGACHEM LIGACHEM 90% Under the terms of the LigaChem Agreement, both parties equally share the costs of developing the ADC products and profits on commercialized products

NextCure, Inc. Customers

TickerNameConfidenceEvidence
LIGACHEM-BIOSCIENCES-INC LIGACHEM-BIOSCIENCES-INC 85% dates we develop and our ability to obtain and maintain regulatory approvals for such product candidates for any indication; ● the identification, analysis and use of biomarkers and biomarker data; ●…

NextCure, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
NXTC-DEBT Debt stack $3.9M 90% Market cache reports total debt of $3.9M.

NextCure, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for NextCure, Inc..

NextCure, Inc. Ownership

HolderNameConfidenceEvidence
NXTC-OWNER-SQUADRON-CAPITAL-MANAGEMENT-LLC Squadron Capital Management LLC 90% 13F overlay lists Squadron Capital Management LLC as top holder; 26 tracked holders.

NextCure, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.